General information and entertainment, not investment advice. The author is not a SEBI-registered adviser or research analyst. No recommendation, no promised returns. Markets carry risk including loss of capital. Figures may not be current. Consult a registered adviser before acting.
1 — At a Glance
Cochin Minerals and Rutile closed FY26 with sales of ₹287 crore, down from ₹319 crore the year before — a 10% step backward. Net profit fell harder, from ₹23.6 crore to ₹12.5 crore, a 47% drop that the company’s own filing partly explains: a ₹5.05 crore impairment on a long-suspended metallisation project landed as an exceptional item, and profit before tax before that charge was ₹23.97 crore.
The operating engine cooled too. Full-year operating profit came in at ₹16 crore against ₹31 crore in FY25, and the operating margin sits at 5.5%, well below the 13% the business managed two years earlier. Yet the balance sheet stayed sturdy: borrowings of ₹6.21 crore against ₹172 crore of net worth, and ₹43.7 crore of cash and bank balances.
The worry signal isn’t only in the numbers. In May 2026 the Enforcement Directorate conducted raids at the Aluva office and senior officials’ residences, and on 5 June the Kerala High Court dismissed the company’s appeal seeking to quash the ED’s proceedings. A company can be debt-free and still have a busy legal calendar.
A 100% export-oriented unit selling synthetic rutile mostly to Japanese buyers, with single-product, single-customer-cluster economics, lives and dies by titanium feedstock prices. This year, prices fell.
The record for FY26: smaller, less profitable, still solvent, and under investigation.
2 — Introduction
Cochin Minerals and Rutile was incorporated in 1989 and began commercial production in 1993. Its single line of business is synthetic rutile — a beneficiated form of ilmenite used as feedstock for titanium and as a flux in welding electrodes — made at an installed capacity of 50,000 MT per annum. It is also described as India’s largest manufacturer of aqua ferric chloride, one of the by-products of the rutile process.
The structure is unusual: a 100% export-oriented unit, certified ISO 9001:2015 and ISO 45001:2018, selling into a concentrated overseas customer base. Per the CARE rating report, synthetic rutile was about 90% of FY25 sales, the top 10 clients contributed roughly 93–94% of revenue, and around 70% of exports went to Japan, with Mitsui and Sumitomo named as key customers.
FY26 was eventful beyond the income statement. The board met on 28 May 2026, approved audited results, and recommended an 80% final dividend (₹8 per ₹10 share). Management churned through the year: Joby Mathew was appointed CFO effective 1 September 2025, Sreedeepa S became Company Secretary in October 2025, and founder Dr S.N. Sasidharan Kartha was named Chairman Emeritus in August 2025.
Running alongside all of this is a long investigative tail — Income Tax search operations dating to January 2019, followed by SFIO and ED proceedings. The May 2026 ED raids and the June court setback are the latest entries.
3 — Business Model: WTF Do They Even Do?
Take ilmenite — a black titanium-iron ore — and chemically strip out the iron until what remains is synthetic rutile, one of the purest forms of titanium. That is the entire show. The company calls itself a zero-waste producer because it sells the iron it removes: ferric chloride for effluent treatment, ferrous chloride, recovered titanium dioxide, and cemox for bricks and tiles. The waste stream became a product line, which is genuinely clever industrial chemistry.
The vulnerability is structural and the company doesn’t hide it. Per the CARE report, ilmenite is sourced largely through imports arranged by its primary customer Mitsui, with about 25–30% bought domestically from Indian Rare Earths Limited. So the same Japanese counterparty sits on both ends of the supply chain — it helps arrange the raw material coming in and buys the finished rutile going out. That is a relationship of considerable trust and considerable concentration.
The model is essentially a spread business: import ilmenite, convert it, export rutile, and pray the gap between the two prices holds. In FY26 it didn’t hold well — the operating margin compressed to 5.5%. CARE noted FY25 saw a 17% volume increase offsetting a 7–8% drop in realisation, and flagged that weak global rutile prices continued to pressure margins.
One installed capacity figure has sat at 50,000 MTPA for over a decade, per the extracted operating data. This is not a business that grows by building; it grows when titanium prices rise. That is a model with one throttle, and someone else’s hand is on it.
Does a 33-year customer relationship count as a moat, or as a single point of failure with good manners?
4 — Financials Overview
Figures are standalone, in ₹ crore.
| Metric | Latest Q (Mar 2026) | YoY (Mar 2025) | QoQ (Dec 2025) |
|---|---|---|---|
| Revenue | 85.54 | 75.41 | 61.62 |
| Operating Profit | 7.81 | 4.38 | 3.45 |
| PAT | 3.31 | 5.52 | 2.98 |
| EPS (₹) | 4.23 | 7.05 | 3.81 |
The March quarter shows revenue rising both year-on-year and sequentially, while PAT fell against the year-ago quarter. The reconciling line is other income, which was a positive ₹4.75 crore in March 2025 and a negative ₹2.46 crore in March 2026 — a swing the data sheet records plainly. Operating profit, the part that comes from making and selling rutile, nearly doubled year-on-year to ₹7.81 crore, even as the headline profit slipped.
Per the FY26 filing, the full year carried a ₹5.05 crore exceptional charge: the company impaired capital work in progress on a metallisation project, long suspended due to short supply of domestic ilmenite, judging future economic benefits negligible. The auditor, Saghesh Kumar & Associates, issued an unmodified opinion.
5 — Market Expectations & Historical Multiples
This section describes how the market is currently pricing the company and how that compares with its own history and peer group. It is descriptive, not predictive.
| Metric | Current | Historical Average | Peer Median |
|---|---|---|---|
| P/E | 15.6x | — | 29.0x |
| EV/EBITDA | 6.1x | — | — |
| P/B | 1.13x | — | — |
| ROE | 9.4% | 16.2% (5-yr) | — |
| ROCE | 13.6% | — | 14.4% |
The market currently pays about 15.6x earnings here, against a peer median near 29x for the broader specialty-chemicals set. Return on equity of 9.4% sits below the company’s own five-year average of 16.2%, and ROCE of 13.6% sits just under the peer median of 14.4%.
What the market appears to be pricing reads off the article’s own facts: a single-product exporter, margins compressed to 5.5% as global rutile realisations fell, revenue down 10%, and an active investigation overhang from the ED and SFIO proceedings. The multiple sits below the peer set while the operating margin sits below the company’s own recent history.
One factual observation about market expectations: the company is priced at roughly half the peer median earnings multiple, while its ROCE runs close to the peer median.
6 — What’s Cooking
The spice this year is mostly legal. Per the company’s disclosures, the Enforcement Directorate conducted simultaneous raids at the Aluva office and senior officials’ residences on 27 May 2026. On 5 June 2026, the Kerala High Court dismissed the company’s writ appeal challenging the ECIR proceedings, with the Division Bench holding that registration of a scheduled offence is not a prerequisite for action under PMLA. The company stated it does not anticipate monetary impact on operations.
Separately, per a December 2025 filing, a GST order dated 12 December 2025 raised a demand of ₹8.14 crore plus penalty of ₹0.81 crore, which the company said it would appeal.
On the lighter side of governance housekeeping, the board on 28 May 2026 recommended an 80% final dividend and appointed Rajesh Jacob, a KSIDC nominee, as Nominee Director.
7 — Balance Sheet
| Item | FY24 | FY25 | FY26 |
|---|---|---|---|
| Net Worth | 148.44 | 165.40 | 172.03 |
| Borrowings | 5.72 | 10.78 | 6.21 |
| Other Liabilities | 86.13 | 89.29 | 69.64 |
| Total Liabilities | 240.29 | 265.47 | 247.88 |
| Total Assets | 240.29 | 265.47 | 247.88 |
Three observations on the numbers:
- Borrowings of ₹6.21 crore against ₹172 crore of net worth give a debt-to-equity of 0.04 — the leverage equivalent of a rounding error.
- Inventory fell from ₹166 crore to ₹125 crore over the year, and cash and bank balances rose to ₹43.7 crore — the working capital partly converted itself back into cash.
- Other liabilities dropped ₹20 crore, mostly trade payables unwinding per the filing’s balance sheet.
A company can run almost debt-free for years and still find its largest liability is a court date.
Net cash stands at roughly ₹37.5 crore — ₹43.7 crore cash and bank minus ₹6.21 crore borrowings.
8 — Cash Flow: Sab Number Game Hai
| Year | Operating | Investing | Financing |
|---|---|---|---|
| FY24 | 6.12 | 0.13 | -6.35 |
| FY25 | 0.97 | 0.45 | -1.41 |
| FY26 | 28.53 | -3.41 | -11.03 |
After two years of operating cash flow barely clearing zero, FY26 generated ₹28.5 crore from operations. The filing’s cash flow statement attributes much of it to a ₹41 crore release as inventories fell. Financing outflow of ₹11 crore covered borrowing repayment and the ₹6.26 crore dividend. The cash that years of swollen inventory had been holding hostage finally came home.
9 — Ratios: Sexy or Stressy?
| Ratio | Value |
|---|---|
| ROE | 9.4% |
| ROCE | 13.6% |
| P/E | 15.6x |
| PAT Margin | 4.4% |
| D/E | 0.04 |
ROE of 9.4% means the equity base is working at a fraction of the 16.2% pace it averaged over five years. ROCE of 13.6% shows capital still earns a respectable return despite the thin margin. The PAT margin of 4.4% is the headline tension — for every ₹100 of rutile sold, ₹4.40 survives to the bottom line, leaving little cushion when realisations fall. Debt-to-equity of 0.04 confirms the company funds itself almost entirely from its own reserves.
10 — P&L Breakdown: Show Me the Money
| Year | Revenue | Operating Profit | Other Income | PAT | EPS (₹) |
|---|---|---|---|---|---|
| FY24 | 300.44 | 39 | 2.85 | 8.59 | 10.97 |
| FY25 | 319.06 | 31 | 8.35 | 23.56 | 30.09 |
| FY26 | 287.19 | 16 | 4.95 | 12.51 | 15.98 |
The trajectory bends downward at the operating line: operating profit fell from ₹39 crore to ₹16 crore across three years even as revenue stayed in a ₹287–319 crore band. Other income is worth watching — at ₹8.35 crore in FY25 it was a meaningful slice next to ₹31 crore of operating profit, and FY25’s profit jump to ₹23.6 crore rode partly on that non-operating line. In FY26, with operating profit halving and other income falling, PAT followed both down. EPS moved in step with PAT (₹30.09 to ₹15.98), with the share count unchanged at 0.78 crore — this is a profit decline, not a dilution artefact.
11 — Peer Comparison
| Company | Sales (Qtr) | PAT (Qtr) | P/E |
|---|---|---|---|
| Pidilite Inds. | 3,583 | 584 | 66.1x |
| Deepak Nitrite | 2,120 | 220 | 39.5x |
| Atul | 1,670 | 211 | 29.0x |
| Aarti Industries | 2,205 | 137 | 41.0x |
| Cochin Minerals | 85.5 | 3.31 | 15.6x |
Cochin is the minnow here — quarterly sales of ₹85 crore against peers running into the thousands of crores. It carries the lowest earnings multiple in the set at 15.6x, against a 92-company median of 29x, while its ROCE of 13.6% sits close to the median of 14.4%. The peer set is a different weight class: large diversified specialty-chemicals names, against one company that makes essentially one product for one export market.
12 — Miscellaneous: Shareholding & Promoters
| Holder | % (Mar 2026) |
|---|---|
| Promoters | 51.35 |
| Institutions (DII) | 0.07 |
| Public | 48.57 |
Promoter holding inched up over the year and shows zero pledging. The largest single promoter is Dr S.N. Sasidharan Kartha at 22.09%, the founder who scaled capacity from 10,000 to 50,000 MTA and now holds the Chairman Emeritus title. Kerala State Industrial Development Corporation holds 13.41% — a state-backed presence on the register, and the source of the newly appointed nominee director.
The promoter family’s recent years have featured Income Tax searches, SFIO scrutiny, and ED proceedings, per the company’s own disclosures — a record worth noting plainly.
13 — Corporate Governance: Angels or Devils?
The audit is clean on its face: Saghesh Kumar & Associates issued an unmodified opinion on the FY26 standalone results, and promoter pledging is nil. Against that sit substantial open items. Per CARE and company filings, Income Tax assessments for FY2011-12 to FY2018-19 were reopened after January 2019 search operations and later settled at the Interim Board of Settlement — but SFIO and ED investigations remain active. The Kerala High Court’s June 2026 dismissal of the company’s appeal keeps the ED matter live. A ₹8.14 crore GST demand from December 2025 is under appeal. The CFO seat changed hands repeatedly across 2025. These are facts on the record; the company states it expects no monetary impact from the ED proceedings.
14 — Industry Roast & Macro Context
The titanium feedstock business is a commodity dressed as a specialty chemical. Per the CARE report, the TiO₂ and rutile markets swung through supply disruptions, geopolitical tension, and softening demand into mid-2025, with slowing growth in Europe and the US and weak housing dragging pigment consumption and rutile prices lower. Ilmenite, the key input, is concentrated in a handful of countries, so producers import their raw material at globally-set prices and sell finished product at globally-set prices — a margin sandwiched between two markets neither can control. Tightening environmental rules and rising production costs add to the squeeze. It’s a sector where being one of the few Indian players is genuinely scarce, and also where that scarcity buys no protection from a price cycle set in Japan and China.
15 — EduInvesting Verdict
| Strengths | Weaknesses |
|---|---|
| Near debt-free; D/E 0.04, ₹37.5 Cr net cash | Operating margin compressed to 5.5% |
| Operating cash flow of ₹28.5 Cr in FY26 | Revenue down 10%, PAT down 47% |
| Opportunities | Threats |
| Volume recovery as rutile cycle turns | Active ED/SFIO investigations |
| Formula-driven pricing with key customers | Client and product concentration; forex risk |
The FY26 record is a company that fortified its balance sheet and freed up cash while its income statement shrank and its legal file thickened. One product, a few customers, a price cycle it doesn’t set, and a courtroom it can’t leave — held up by a balance sheet with almost nothing owed to anyone but the questions it still has to answer.